2:22cv5258 • August 26, 2022
Class Period Start
May 15, 2020
Class Period End
October 10, 2022
PSLRA Deadline
October 25, 2022
Case Allegations
10b5
Statutes of Repose
May 15, 2023
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
March 7, 2024
Settlement Fund
$3,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or acquired Humanigen securities during the period from May 16, 2020, to July 12, 2022, inclusive.
Claim Administrator
A.B. Data, Ltd.
HUMANIGEN, INC. SECURITIES LITIGATION
Claims Administrator
c/o A.B. Data, Ltd.
P.O. Box 173107
Milwaukee, WI 53217
+1 877-354-3785
[email protected]
Settlement Website
https://humanigensecuritieslitigation.com/Hearing Date
March 7, 2024
Opt-out Deadline
February 8, 2024
Settlement Note
Download hereProof Of Claim
Download here
Mar 13, 2025
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Sep 13, 2024
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Jul 30, 2024
Motion for Final Approval of Settlement
The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.
Nov 8, 2023
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Nov 8, 2023
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Sep 22, 2023
Jul 7, 2023
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Mar 27, 2023
A new complaint has been filed on behalf of certain investors in HUMANIGEN, INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Dec 9, 2022
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Oct 17, 2022
Aug 26, 2022
A securities fraud class action complaint has been filed on behalf of certain investors in HUMANIGEN, INC.
TOP
